Cyprus Mail

Coronavirus: WTO meeting on COVID vaccine rights waiver went ‘very well’

vaccine waiver
Members of aid group Doctors Without Borders (MSF) demonstrate outside the World Trade Organization to waive intellectual property rights on coronavirus disease (COVID-19) drugs ahead of next week meeting on WTO's Trade-Related Aspects of Intellectual Property (TRIPS) agreement in Geneva, Switzerland March 4, 2021

The first World Trade Organization meeting to discuss a draft agreement to temporarily waive intellectual property rights for COVID-19 vaccines went “very well”, its chair said on Friday, although some members voiced reservations.

The WTO’s 164 members on Friday discussed the “outcome document” that stems from months of negotiations between the main parties – the United States, the European Union, India and South Africa – in an effort to break an 18-month deadlock over the issue.

“It went very well and here’s why I say that. No member rejected the outcome as completely unacceptable,” Ambassador Lansana Gberie from Sierra Leone, who chairs the council tasked with finding an agreement on the waiver, told Reuters after the closed-door meeting.

“Most said this could be developed into a negotiating text and that’s the trajectory we have to follow.”

However, two Geneva trade sources said after the meeting that some delegations had said the proposal fell short since it was too narrowly focused on vaccines, echoing criticism from some civil society groups.

And while China voiced broad support for the document it also raised an objection to some of the wording that appeared to exclude it from the waiver on the basis of its global share of vaccine exports, the two sources said.

China’s statement sent by its WTO mission in Geneva called the wording “an unreasonable and arbitrary criterion”.

The waiver idea, proposed by India and South Africa in October 2020, is supported by the majority of members of the global trade body.

But some wealthy countries including Britain and Switzerland have in the past raised objections on grounds that it could harm pharmaceutical research.

WTO Director-General Ngozi Okonjo-Iweala, who has been involved in brokering the talks and wants a deal by the June ministerial conference, says an agreement would be “hugely important”.

The new draft deal, which has unresolved areas, must pass by consensus and any member of the organisation has the right to a veto.

One delegate described Friday’s meeting as the moment the deal would “float or sink”.

Privately, some delegates have said a lack of public support for the deal by the main negotiating parties has sapped confidence among other members.

Follow the Cyprus Mail on Google News

Related Posts

Hamas says Israeli hostages have suffered many losses

Reuters News Service

Greek same-sex couples race to wed after historic vote

Reuters News Service

Greece to suspend flights at Crete airport for six days

Reuters News Service

Israel bombards Gaza, with biggest functioning hospital under siege

Reuters News Service

Putin opponent Navalny dies in Arctic jail, Russia says

Reuters News Service

Greece legalises same sex marriage in landmark change

Reuters News Service